*Streptococcus suis* is a commensal organism of the upper respiratory tract of pigs that can occasionally cause severe invasive infections in these animals ([@R1],[@R2]). The bacterium also can infect humans who have close contact with pigs or pork products, leading to serious diseases such as meningitis, endocarditis, and sepsis ([@R3]). *S. suis* can survive in dust, manure, and pig carcasses for days or even weeks under optimal conditions; therefore, the working environments in slaughterhouses and farms can be a source of human infection ([@R3],[@R4]). Meningitis is the most common clinical manifestation of *S. suis* infection in humans and has an estimated case-fatality rate of 3% ([@R2]). Whereas this zoonotic pathogen is among the leading causes of adult meningitis in some countries of Southeast Asia ([@R5]), its incidence in Africa is largely unknown. We report 21 retrospectively confirmed cases of *S. suis* meningitis in Burkina Faso.

The Study
=========

Burkina Faso conducts nationwide case-based surveillance for bacterial meningitis. Cerebrospinal fluid (CSF) samples collected from patients with suspected meningitis are sent to 1 of 5 national laboratories for confirmation by culture and real-time PCR testing ([@R6]). Because of multiple challenges encountered by the laboratories in isolating bacteria from CSF, the confirmation of meningitis cases relies heavily on molecular detection ([@R6]). The real-time PCR assay currently used at the national laboratories only detects *Streptococcus pneumoniae*, *Neisseria meningitidis*, and *Haemophilus influenzae*. Between 2015 and 2018, the national laboratories tested 7,174 CSF samples from patients with suspected meningitis nationwide. Of these, 4,930 (68.7%) were PCR-negative for *S. pneumoniae*, *N. meningitidis*, and *H. influenzae*. To further investigate suspected meningitis cases that were PCR-negative after testing for the 3 pathogens, a subset of specimens was selected for additional screening based on leukocytes counts [\>]{.ul}50 cells/mm^3^. In total, 912 PCR-negative specimens were available for the study; among these, 590 fit the selection criteria. The specimens were retested by using a triplex direct real-time PCR that was designed for the simultaneous detection of *Streptococcus agalactiae* (group B *Streptococcus* \[GBS\]), *S. pyogenes* (group A *Streptococcus* \[GAS\]), and *S. suis*. The nucleotide sequences and final concentrations of the primers and probes used in this assay ([Table 1](#T1){ref-type="table"}) were identical to those used in singleplex real-time PCR methods ([@R7]--[@R10]), with the exception that FAM was replaced by HEX as the reporter dye for *cfb*-specific probes for the GBS target and by Cy5 as the reporter dye for *spy*-specific probes for the GAS target. Each reaction was prepared in a final volume of 25 µL, including 1 µL of each primer and probe, 2 µL of CSF as DNA template, 12.5 µL of PerfeCta MultiPlex qPCR ToughMix mastermix (QuantaBio, <https://www.quantabio.com>), and 1.5 µL of PCR-grade water. The thermal profile for the real-time PCR runs was 1 cycle of 55°C for 5 min, 1 cycle of 95°C for 10 min, then 40 cycles of 95°C for 15 s and 60°C for 1 min. All specimens were tested by real-time PCR for the presence of the human ribonuclease P (RNaseP) gene to check for the presence of inhibitors. A specimen was considered positive if the cycle threshold (C~t~) for 1 of the bacterial targets was [\<]{.ul}35 and was considered negative if the C~t~ was [\>]{.ul}40 for all bacterial targets with C~t~[\<]{.ul}35 for RNaseP. If C~t~ was between 35 and 40 for the bacterial targets and [\<]{.ul}35 for RNaseP, the specimen is retested; if the result was reproducible, it was considered positive. The lower limits of detection (LLDs) were determined as previously described ([@R11]). The LLD of the direct triplex assay (3 CFU/µL for *S. suis*, 28 CFU/µL for GBS, and 26 CFU/µL for GAS) were compared with the LLD of the triplex assay conducted on DNA extracted from the same serial dilutions (2 CFU/µL for *S. suis*, 5 CFU/µL for GBS, and 3 CFU/µL for GAS).

###### Sequences and concentrations of primers and probes used to detect *Streptococcus suis*, *S. agalactiae*, and *S. pyogenes*, Burkina Faso\*

  Target gene                 Forward primer, 5¢ ® 3¢      Reverse primer, 5¢ ® 3¢      Probe, 5¢ ® 3¢                                                  Concentration of oligo per reaction, nM†
  --------------------------- ---------------------------- ---------------------------- --------------------------------------------------------------- ------------------------------------------
  *cfb* ([@R7]), GBS          GGGAACAGATTATGAAAAACCG       AAGGCTTCTACACGACTACCAA       AGACTTCATTGCGTGCCAACCCTGAGAC 5¢-HEX; 3¢-BHQ1                    200/200/200
  *fbpS* ([@R8]), *S. suis*   TCCRATRCTGCTCTGCCATT         TGATAGTAGAAGTCCAGCARACT      AATAGCCC"T"GAAAAMCAGCCACWYTTTGARA 5¢-FAM; 3¢-SpC6; "T" = BHQ1   200/200/100
  *spy* ([@R9]), GAS          GCACTCGCTACTATTTCTTACCTCAA   GTCACAATGTCTTGGAAACCAGTAAT   CCGCAAC"T"CATCAAGGATTTCGTTACCA 5¢-Cy-5; 3¢- SpC6; "T" = BHQ2    300/300/100
  RNaseP ([@R10])             AGATTTGGACCTGCGAGCG          GAGCGGCTGTCCCACAAGT          TTCTGACCTGAAGGCTCTGCGCG 5¢-FAM; 3¢-BHQ1                         400/400/100

\*GAS, group A *Streptococcus* (*Streptococcus pyogenes*); GBS, group A *Streptococcus* (*S. agalactiae*); RNaseP, human ribonuclease P. †Concentration of forward primer/reverse primer/probe.

Among the specimens tested, 21 were positive for *S. suis*, 13 for GAS, and 4 for GBS ([Table 2](#T2){ref-type="table"}). Of the 21 *S. suis*--positive case-patients, 1 was 4 years of age, 3 were 5--14 years of age, 2 were 15--29 years of age, 9 were 30--49 years of age, and 6 were [\>]{.ul}50 years of age; 16 (76.2%) were male and 5 (23.8%) were female. Two (9.5%) patients died, 14 recovered, and the outcome for 5 was unknown. Eight (61.5%) of the GAS-positive case-patients were \<5 years of age and 5 were 5--14 years of age; 1 (7.7%) patient died, 5 recovered, and the outcome for 7 was unknown. All the GBS-positive case-patients were [\<]{.ul}6 months of age and all recovered. Median time from symptom onset to CSF collection was 2 days (range 1--10 days) for all the patients.

###### Characteristics of patients with meningitis caused by *Streptococcus suis*, *S. pyogenes*, and *S. agalactiae*, Burkina Faso, 2015--2018\*

  Characteristics                          Patients infected, no. (%)   All patients, no. (%), n = 590                         
  ---------------------------------------- ---------------------------- -------------------------------- --------------------- ----------------------
  Age, y                                                                                                                       
  \<5                                      1 (4.8)                      8 (61.5)                         4 (100)               307 (52)
  5--14                                    3 (14.3)                     5 (38.5)                         0                     168 (28.5)
  15--29                                   2 (9.5)                      0                                0                     64 (10.8)
  30--49                                   9 (42.8)                     0                                0                     37 (6.3)
  [\>]{.ul}50                              6 (28.6)                     0                                0                     14 (2.4)
  Sex                                                                                                                          
  M                                        16 (76.2)                    9 (69.2)                         2 (50)                332 (56.3)
  F                                        5 (23.8)                     4 (30.8)                         2 (50)                258 (43.7)
  Year CSF collected                                                                                                           
  2015                                     5 (23.8)                     1 (7.7)                          0                     87 (14.7)
  2016                                     2 (9.5)                      2 (15.4)                         0                     104 (17.6)
  2017                                     6 (28.6)                     3 (23.1)                         2 (50)                195 (33.1)
  2018                                     8 (38.1)                     7 (53.8)                         2 (50)                204 (34.6)
  Median leukocytes, cells/mm^3^ (range)   400 (51--6,250)              1,000 (53--8,000)                1,100 (800--2,400)    920 (50--8,000)
  Median C~t~ (range)                      26.1 (18.13--35.52)          25.33 (14.78--34.71)             23.47 (17.24−24.23)   25.33 (14.78--35.52)

\*CSF, cerebrospinal fluid; C~t~, cycle threshold.

*S. suis*--positive cases were found among specimens from rural districts in 10/13 regions of the country with 28% (6/21) from the Centre-Est Region and 19% (4/21) from the Plateau Central Region. All adults with *S. suis* were farmers. Because of the retrospective detection of the etiology, the extent of any direct exposure of the *S. suis*--positive patients to pigs or pork products was unknown and attempts to collect additional information from the patients or their families were unsuccessful.

Small-scale pig farming is a major economic activity in most parts of Burkina Faso. Although porcine-related occupations, undercooked pork consumption, and exposure to pigs have been identified as major risk factors for *S. suis* infection ([@R5]), its occurrence in a wide range of animal species have been reported ([@R2]).

DNA extracted from the *S. suis*--positive specimens were used for a multiplex conventional PCR for serotype detection ([@R12]). All the specimens were serotype 2 or 1/2 because the method used here could not clearly differentiate serotypes 2 and 1/2. Bacterial isolates from these cases were not available for further characterization. Serotype 2 is believed to cause 74%--95% of human cases of *S. suis* infections reported worldwide, but serotype 1/2 has not been reported to cause disease in humans ([@R1],[@R2]).

Conclusions
===========

Limited data are available regarding the incidence of streptococcal infections in Africa, and the disease burden likely is underestimated, especially for disease caused by *S. suis*. Two reported studies conducted in Togo identified 16 human cases of *S. suis* meningitis during 2010--2015 caused by serotype 2 ([@R13],[@R14]). Another recent study in Madagascar described 2 human cases of *S. suis* meningitis, also caused by serotype 2 ([@R15]).

Our study reports 21 cases of *S. suis* meningitis from 2015--2018 in Burkina Faso. *S. suis* infections more commonly are observed in adult males and are directly correlated with occupational exposure to pigs or pork products ([@R2],[@R13],[@R15]). All adult cases reported here were farmers, although their exposure to pigs or pork was unknown. The presence of children among the patients in this study and in previous studies ([@R13]) indicates that older children also should be considered at risk. Finding 21 cases of this outbreak-prone zoonotic pathogen in this study raises concern about the incidence of *S. suis* disease in Burkina Faso and in other parts of Africa where pigs are raised. Prospective surveillance for *S. suis* could help identify farming communities where measures to prevent disease and its potential socioeconomic damages are needed.
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